[REGN] QoQ Quarter Result on 31-Mar-2013 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
03-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- -78.98%
YoY- 748.63%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 610,412 597,027 457,642 439,664 414,602 427,687 304,399 58.81%
PBT 198,153 225,684 147,692 141,831 134,559 191,468 76,743 87.88%
Tax 101,347 84,378 60,316 42,957 -335,848 -517 -501 -
NP 96,806 141,306 87,376 98,874 470,407 191,468 76,743 16.69%
Tax Rate -51.15% -37.39% -40.84% -30.29% 249.59% 0.27% 0.65% -
Total Cost 513,606 455,721 370,266 340,790 -55,805 236,219 227,656 71.76%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 15.86 23.67 19.09 22.49 113.46 44.77 25.21 -26.51%
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
EPS 0.98 1.44 0.89 1.02 4.92 2.02 0.81 13.50%
EPS Diluted 0.73 1.25 0.79 0.90 4.26 1.72 0.70 2.82%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.